SE7608611L - WAY TO PREPARE AN ORALLY INTAKE PHARMACEUTICAL COMPOSITION - Google Patents

WAY TO PREPARE AN ORALLY INTAKE PHARMACEUTICAL COMPOSITION

Info

Publication number
SE7608611L
SE7608611L SE7608611A SE7608611A SE7608611L SE 7608611 L SE7608611 L SE 7608611L SE 7608611 A SE7608611 A SE 7608611A SE 7608611 A SE7608611 A SE 7608611A SE 7608611 L SE7608611 L SE 7608611L
Authority
SE
Sweden
Prior art keywords
prepare
way
pharmaceutical composition
orally
intake
Prior art date
Application number
SE7608611A
Other languages
Swedish (sv)
Inventor
R B Clark
S H Ferreira
N B Mehta
P B Thorogodd
R Vinegar
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7608611L publication Critical patent/SE7608611L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7608611A 1975-07-31 1976-07-30 WAY TO PREPARE AN ORALLY INTAKE PHARMACEUTICAL COMPOSITION SE7608611L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3200575 1975-07-31
GB3200475 1975-07-31
GB2718476 1976-06-30

Publications (1)

Publication Number Publication Date
SE7608611L true SE7608611L (en) 1977-02-01

Family

ID=27258606

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608611A SE7608611L (en) 1975-07-31 1976-07-30 WAY TO PREPARE AN ORALLY INTAKE PHARMACEUTICAL COMPOSITION

Country Status (10)

Country Link
JP (1) JPS5218831A (en)
AU (1) AU1643776A (en)
DE (1) DE2634409A1 (en)
DK (1) DK345676A (en)
FR (1) FR2319346A1 (en)
IL (1) IL50174A0 (en)
LU (1) LU75513A1 (en)
NL (1) NL7608503A (en)
NZ (1) NZ181635A (en)
SE (1) SE7608611L (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
IT1194677B (en) * 1980-08-05 1988-09-22 Italfarmaco Spa PHARMACEUTICAL COMPOSITION WITH ANTI-FLOGISTIC, ANTIPIRETIC AND ANALGIC ACTIVITY
DE3508665A1 (en) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt HETEROCYCLIC SULFIDES AND THEIR USE AS IMMUNO MODULATORS
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US5164406A (en) * 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition

Also Published As

Publication number Publication date
DK345676A (en) 1977-02-01
DE2634409A1 (en) 1977-02-17
LU75513A1 (en) 1977-04-15
AU1643776A (en) 1978-02-02
IL50174A0 (en) 1976-09-30
FR2319346A1 (en) 1977-02-25
FR2319346B1 (en) 1979-05-25
NZ181635A (en) 1978-09-25
NL7608503A (en) 1977-02-02
JPS5218831A (en) 1977-02-12

Similar Documents

Publication Publication Date Title
SE432247B (en) SET TO MAKE DIHYDRO-CYCLOSPORINE C
SE433222B (en) SET TO MAKE MODIFIED POLYSACARIDE
SE7604837L (en) WAY TO INFORLATE GAS IN CARAMEL
SE422077B (en) SET TO MAKE SYNTHESAL GAS
SE7600277L (en) WAY TO PREPARE SAMPOLYMERISATE POWDER
SE7606280L (en) WAY TO PREPARE ETHARS
SE433492B (en) SET TO MAKE PHENYLETIC ACID DERIVATIVES
SE7608799L (en) WAY TO PREPARE CHROMANON (4)
SE420728B (en) PUT TO MAKE PIPERAZINYLIMINORIFAMYCINES
SE417507B (en) SET TO PREPARE 2-ARYLAMINO-2-IMIDAZOLINE DERIVATIVES
SE7606484L (en) WAY TO PRODUCE HOGHALL FIXED CEMENT CONGLOMATED
SE416239B (en) SET TO IDENTIFY FLUORESCEN SUBJECTS
SE420602B (en) SET TO PREPARE PYRAZINE-3-METOXI-2-CARBOXAMIDE DERIVATIVES
BE826935A (en) ANTIVIRAL PHARMACEUTICAL COMPOSITIONS
SE424991B (en) SET TO MAKE NEW 5-PHENYL-OXAZOLIDINONES
SE7608611L (en) WAY TO PREPARE AN ORALLY INTAKE PHARMACEUTICAL COMPOSITION
SE430156B (en) SET TO MAKE 2-SUBST-1- (OMEGA-AMINOAL COCOY) BENZENER
SE425390B (en) SET TO MAKE NEW 11-OXO PROSTAGLAND INGREDIENTS
SE427655B (en) SET TO MAKE ABIETAMIDE DERIVATIVES
SE7608939L (en) WAY TO PRODUCE PYRROLINE DERIVATIVES
SE7607171L (en) WAY TO PRODUCE INDOLOKINOLIZINES
SE420731B (en) SET TO MAKE 5-ANDROSTEN-17-ON DERIVATIVES
SE7601564L (en) WAY TO MAKE TABLETS
SE412233B (en) SET TO MAKE NEW PHENOTIAZINE DERIVATIVES
SE7605357L (en) WAY TO PRODUCE NEW CEFEM ASSOCIATIONS